慢性HBV感染者肝脏病理改变的研究进展

尚丹鹤; 陈延平; 李春艳

doi:10.3969/j.issn.1001-5256.2013.11.018

慢性HBV感染者肝脏病理改变的研究进展

DOI: 10.3969/j.issn.1001-5256.2013.11.018

延安大学附属医院感染病科

基金项目:

延安市科技局基金项目(2008KS-19)；延安大学附属医院研究生创新基金项目(10YJ24)；

详细信息

中图分类号: R512.62
计量
- 文章访问数: 2827
- HTML全文浏览量: 21
- PDF下载量: 653
- 被引次数: 0
出版历程
- 收稿日期: 2013-03-25
- 出版日期: 2013-11-20

The research in liver tissue pathology of chronic HBV infection patients

Department of Infectious Diseases, Yan' an Univestity Affiliated Hospital

Research funding:

摘要

摘要: 肝组织病理学检查是反映慢性HBV感染者肝脏病变程度最直接的指标。通常认为血清转氨酶正常或轻度异常[<2×正常值上限(ULN)]的慢性HBV感染者肝脏病变程度轻微,然而近年来多数学者发现部分转氨酶<2×ULN的患者肝脏病理改变程度严重。对慢性HBV感染者临床特征与肝脏肝组织病理改变程度的关系进行论述,系统地了解了转氨酶<2×ULN慢性HBV感染者的病理与临床特征,并认为年龄、性别、HBeAg状态、HBV DNA及ALT水平等与其均具有一定的关系,监测这些因素有助于更全面地明确慢性HBV感染者肝脏病理改变程度。
- 转氨酶类 /
- 肝炎,乙型,慢性 /
- 肝炎病毒,乙型 /
- 肝脏病理
Abstract: Histopathological examination of the liver is the most direct method for evaluating the pathological changes of the liver in patients with chronic hepatitis B virus ( HBV) infection. Generally, the patients with chronic HBV infection who show normal or slightly elevated serum alanine transaminase ( ALT) levels ( < 2 × ULN) are considered to have mild hepatic fibrosis or inflammation. However, in recent years, many scholars have found that some patients with serum ALT levels below 2 × ULN have severe pathological changes. The relationship between clinical features and pathological changes of the liver in patients with chronic HBV infection is reviewed, and the pathological and clinical features of chronic HBV infection patients with serum ALT levels below 2 × ULN are understood systematically. Age, sex, HBeAg status, HBV DNA level, and ALT level are considered to have certain relationship with these features. Monitoring of these factors is helpful for comprehensive evaluation of pathological changes of the liver in patients with chronic HBV infection.
- transaminases /
- hepattitis B, chronic /
- hepatitis B virus /
- hepatic histopathology

HTML全文

参考文献(1)

[1]LIAW YF, LEUNG N, KAO JH, et al.Asian-Pacific consensus statement on the management of chronic hepatitis B:a 2008 update[J].Hepatol Int, 2008, 2 (3) :263-283.[2]LOK AS, McMAHON BJ.Chronic hepatitis B:update 2009[J].Hepatology, 2009, 50 (3) :661-662.[3]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].J Clin Hepatol, 2011, 27 (1) :1-16. (in Chinese) 中华医学肝病学分会, 中华医学会感染分会.中国慢性乙型肝炎防治指南 (2010版) [J].临床肝胆病杂志, 2011, 27 (1) :1-16.[4]CHEN EQ, HE LL, WANG LC, et al.Change of liver histology in chronic hepatitis B patients with alanine aminotransferase less than two-time up limits of normal[J].World Chin J Dig, 2008, 16 (22) :2476-2481. (in Chinese) 陈恩强, 何伶俐, 王丽春, 等.丙氨酸氨基转移酶低于2倍正常值的慢性乙肝患者肝组织学的改变[J].世界华人消化杂志, 2008, 16 (22) :2476-2481.[5]KE J, XIE QX, ZHANG YF, et al.Influential factors for liver pathology in patients with chronic HBV infection:an analysis of 129cases[J].Chin J Infect Dis, 2012, 30 (8) :490-492. (in Chinese) 柯晶, 谢琴秀, 张亚飞, 等.慢性乙型肝炎病毒感染的129例患者肝组织学影响因素分析[J].中华传染病杂志, 2012, 30 (8) :490-492.[6]YING RS, YANG Z, CHEN YY, et al.Different liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT[J].Chin J Hepatol, 2012, 20 (8) :585-588. (in Chinese) 应若素, 杨湛, 陈燕宇, 等.丙氨基转移酶水平正常与轻度升高慢性HBV感染者的肝脏病理学特征比较[J].中华肝脏病杂志, 2012, 20 (8) :585-588.[7]HSU A, LAI CL, YUEN MF.Update on the risk of hepatocellular carcinoma in chronic hepatitis B virus infection[J].Curr Hepat Rep, 2011, 10 (2) :106-111.[8]CHU CM, LIAW YF.Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus[J].Am J Gastroenterol, 2009, 104 (7) :1693-1699.[9]LI L, YU HB, LYU J, et al.Analysis of risk factors about disease progression in patients with HBeAg positive chronic hepatitis B receiving liver biopsy[J].Beijing Med J, 2010, 32 (3) :210-213. (in Chinese) 李丽, 于海滨, 闾军, 等.HBeAg阳性慢性乙型肝炎肝活检患者病情进展的危险因素分析[J].北京医学, 2010, 32 (3) :210-213.[10]ZHENG Z.Relationship between HBV-DNA and HBeAg'aspartate aminotransferase and alanine aminotransferase in chronic hepatitis B patients with positive e Antigen[J].J Med Res, 2012, 41 (8) :164-166. (in Chinese) 郑专.e抗原阳性的乙型肝炎患者HBV-DNA载量与HBsAg以及肝功能关系的研究[J].医学研究杂志, 2012, 41 (8) :164-166.[11]ZENG DW, DONG J, ZHU YY, et al.The relationship between different serum HBeAg levels and pathological stages of patients with chronic hepatitis B[J].Chin J Infect Dis, 2012, 30 (8) :468-471. (in Chinese) 曾达武, 董菁, 朱月永, 等.HBeAg水平与免疫耐受期慢性乙型肝炎患者的临床病理关系[J].中华传染病杂志, 2012, 30 (8) :468-471.[12]TANG X, YUAN T, WANG M, et al.Pathological changes of liver in HBeAg-positive and HBeAg-negative patients with chronic hepatitis B:a comparative analysis of 171 cases[J].Pract Clin Med, 2011, 12 (7) :8-9. (in Chinese) 汤雄, 袁涛, 汪梦, 等.171例HBeAg阳性与阴性慢性乙型肝炎患者肝脏组织学的对比分析[J].实用临床医学, 2011, 12 (7) :8-9.[13]WU LP, ZHANG JJ, DU RQ, et al.The correlation between HBV DNA and liver inflammation/fibrosis stage in HBeAg positive and negative chronic hepatitis B patients[J].Chin Hepatol, 2009, 14 (2) :269-271. (in Chinese) 吴丽萍, 张建军, 杜瑞清, 等.肝功能正常的慢性乙型肝炎病毒感染者血清HBeAg及HBV DNA与肝组织病理改变的关系[J].肝脏, 2009, 14 (2) :269-271.[14]MO ML, MO RH, GAN CL, et al.Study on correlation between serum HBeAg/HBV DNA level and pathological changes of liver tissues[J].J Clin Hepatol, 2009, 25 (4) :256-258. (in Chinese) 莫穆隆, 莫让辉, 甘楚林, 等.血清HBeAg、HBV DNA与肝组织病理的相关性分析[J].临床肝胆病杂志, 2009, 25 (4) :256-258.[15]WU CH, SI CW, TIAN GS, et al.An analysis of the pathohistology of liver tissues, clinical features and prognostic factors of chronic hepatitis B virus carriers[J].Chin J Hepatol, 2007, 15 (8) :577-581. (in Chinese) 吴赤红, 斯崇文, 田庚善, 等.慢性乙型肝炎病毒携带者的病理与临床及预后分析[J].中华肝脏病杂志, 2007, 15 (8) :577-581.[16]ZHOU WH, CHEN SY, FEI XW.The relation study between serum quantitative HBV-DNA, ALT level and liver lesions in patients with chronic hepatitis B[J].Exp Lab Med, 2011, 29 (4) :369-372. (in Chinese) 周文虹, 陈书裕, 费选文.慢性乙肝患者HBV-DNA定量与肝脏病理及血清ALT关系的探讨[J].实验与检验医学, 2011, 29 (4) :369-372.[17]AHN SH, CHANH LY.CHEN PJ, et al.Chronic hepatitis B:whom to treat and for how long?Propositions, challenges, and future directions[J].Hepatol Int, 2010, 4 (1) :386-395.[18]PARK BK, PARK YN, AHN SH, et al.Long-term outcome of chronic hepatitis B based on histological grade and stage[J].J Gastroenterol Hepatol, 2007, 22 (3) :383-388.[19]DOU XG.Anti-virus treatment strategies for chronic hepatitis B virus infection with normal alanine aminotransferase[J].Chin J Pract Intern Med, 2013, 33 (6) :454-456. (in Chinese) 窦晓光.丙氨酸转氨酶正常的慢性乙型肝炎病毒感染人群抗病毒治疗策略[J].中国实用内科杂志, 2013, 33 (6) :454-456.[20]TAI DI, LIN SM, SHEE IS, et al.Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time[J].Hepatology, 2009, 49 (6) :1859-1867.[21]LIAW YF, CHU CM.Hepatitis B virus infection[J].Lancet, 2009, 373 (9663) :582-592.[22]KIM WR, FLAMM SL, Di BISCEGLIE AM, et al.Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease[J].Hepatology, 2008, 47 (4) :1363-1370.[23]PARK JY, PARK YN, KIM DY, et al.High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels[J].J Viral Hepatol, 2008, 15 (8) :615-621.[24]TSANG PS, TRINH H, GARCIA RT, et al.Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels[J].Clin Gastroenterol Hepatol, 2008, 6 (5) :569-574.[25]LAI M, HYATT BJ, NASSER I, et al.The clinical significance of persistently normal ALT in chronic hepatitis B infection[J].J Hepatol, 2007, 47 (6) :760-767.[26]LESMANA CR, GANI RA, HASAN I.Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia[J].J Dig Dis, 2011, 12 (6) :476-480.[27]ALAM S, AHMAD N, MUSTAFA G, et al.Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B[J].Liver Int, 2011, 31 (6) :824-830.[28]PARTI D, TAIOLI E, ZANELLA A, et al.Updated definition of healthy ranges for serum alanine aminotransferase levels[J].Ann Intern Med, 2002, 137 (1) :1-10.[29]SHANG DH, CHEN YP, XU GH, et al.Study on liver pathology in chronic hepatitis B patients with different ALT levels[J].Chin J Infect Dis, 2013, 31 (3) :183-184. (in Chinese) 尚丹鹤, 陈延平, 徐光华, 等.不同丙氨酸转移酶水平慢性乙型肝炎患者肝组织的病理学研究[J].中华传染病杂志, 2013, 31 (3) :183-184.[30]LIN CL, KAO JH.The clinical implications of hepatitis B virus genotype:Recent advances[J].J Gastroenterol Hepatol, 2011, 26 (Suppl 1) :123-130.[31]HUANG Y, WANG Z, AN S, et al.Role of hepatitis B virus genotypes and quantitative HBV DNA in metastasis and recurrence of hepatocellular carcinoma[J].J Med Virol, 2008, 80 (4) :591-597.[32]MOLINA-PREZ E, CASTROAGUDN JF, AGUILERA-GUIRAO A, et al.Viral and host factors related with histopathologyc activity in patients with chronic hepatitis B and moderate or intermittently elevated alanine aminotransferase levels[J].Rev Esp Enferm Dig, 2010, 102 (9) :519-525.[33]SáNCHEZ-TAPIAS JM, COSTA J, MAS A, et al.Influence of hepatitis B genotype on the long-term outcome of chronic hepatitis B in western patients[J].Gastroenterology, 2002, 123 (6) :1848-1856.[34]HE WP, HU JH, WANG HF.Relativity analysis of chronic hepatitis B virus genotype and clinical pathology[J].Chin J Exp Clin Virol, 2008, 22 (2) :116-118. (in Chinese) 何卫平, 胡瑾华, 王慧芬.慢性乙型肝炎病毒基因型与临床病理相关性分析[J].中华实验和临床病毒学杂志, 2008, 22 (2) :116-118.[35]ZHANG H, ZOU HB, MI YQ, et al.The relationship between HBV genotype and liver biopsy outcome of chronic HBV carriers[J].J Clin Hepatol, 2008, 24 (6) :413-414. (in Chinese) 张弘, 邹怀宾, 宓余强, 等.乙肝病毒携带者病毒基因型与肝组织病理变化的关系[J].临床肝胆病杂志, 2008, 24 (6) :413-414.[36]XIANG WQ, FENG WF, KE W, et al.Hepatitis B virus X protein stimulates IL-6 expression in the patocytes via a My D88-dependent pathway[J].J Hepatol, 2011, 54 (1) :26-33.[37]WANG F, ZHOU H, YANG Y, et al.Hepatitis B Virus X protein promotes the growth of hepatocellular carcinoma by modulation of the Notch signaling pathway[J].Oncol Rep, 2012, 27 (4) :1170-1176.

施引文献

资源附件(0)

访问统计